4.1 Phased Migration Roadmap and Legacy Infrastructure Integration
The structured execution of an institutional zero-trust readiness audit requires a diagnostic decision model that prioritizes continuous identity verification and granular network micro-segmentation over static perimeter defense mechanisms. Implementing zero-trust architectural principles in life-science enterprise environments demands systematic evaluation criteria focused on security effectiveness, scalability, adaptability, and cost efficiency across complex biomedical research workflows (Crossref-10-2139-Ssrn-6962724, 2026). Rather than executing an abrupt, monolithic security overhaul of active laboratory computational systems, the audit methodology establishes a phased deployment protocol that systematically benchmarks operational dependencies and device vulnerabilities within legacy platforms. This diagnostic procedure evaluates multi-factor authentication, identity-centric access control, and zero-trust network access mechanisms to eradicate implicit trust, restrict lateral threat movement, and minimize organizational attack surfaces across clinical infrastructure (15044499, 2023) and broader research networks (Crossref-10-2139-Ssrn-6962724, 2026). Furthermore, the assessment framework explicitly addresses the technical constraints associated with legacy system integration, high deployment costs, and specialized skill shortages, which constitute primary barriers to adoption within complex enterprise architectures (Crossref-10-2139-Ssrn-6962724, 2026). By evaluating granular micro-segmentation boundaries and continuous access controls, the diagnostic audit enables life-science security administrators to inspect resource-level permissions and isolate sensitive clinical data repositories without interrupting ongoing laboratory research operations (15044499, 2023). Applying these diagnostic criteria ensures that the host firm establishes empirical baseline requirements before committing capital resources, thereby enabling resilient hybrid cloud orchestration, mitigating access vulnerabilities, and maintaining regulatory compliance across all digital life-science environments.